Colon cancer Data

In the world

0
New cases / year
0
Death / year
0th
Rank of cancer deaths

In Europe

0
New cases / year
0
Death / year
0nd
Rank of cancer deaths

Source : GLOBOCAN 2022

Cyberna is developing an innovative in vitro diagnostic (IVD) test for early detection of colorectal cancer and advanced adenoma (precancerous lesions) through a simple blood drop

Indicated for:

Adults at average risk for colorectal cancer (age > 50, no personal or family history of colorectal cancer, and no personal history of polyps).

Key features:

  • Non-invasive: Easy, at-home sample collection.

  • Advanced detection: Analyzes RNA chemical modifications in circulating blood.
  • Early insights: Detects early tumor microenvironment changes at the RNA level.

  • Real-time observation: Provides real-time information about the state of the tumor

  • Cutting-edge technology: epitranscriptomic signature developed by identification and analysis of nucleoside biomarkers using mass spectrometry combined with artificial intelligence (machine learning)
  • Fast results: Quick turnaround time.
  • Affordable: Designed to be cost-effective.

  • Accessible, easy to integrate & Scalable: offered as a Software-as-a-Service (Saas) platform

Ready to talk?